What is Chartspan Medical Technologies?
ChartSpan is recognized as the leading Chronic Care Management company in the United States. It provides comprehensive value-based care solutions designed to enhance patient outcomes and optimize provider efficiency. The company's platform facilitates effective management of chronic conditions, aligning with the shift towards value-based reimbursement models in healthcare. This strategic focus positions ChartSpan at the forefront of healthcare innovation, addressing critical needs in patient care and operational management for healthcare systems.
How much funding has Chartspan Medical Technologies raised?
Chartspan Medical Technologies has raised a total of $38.1M across 7 funding rounds:
Other Financing Round
$250K
Angel/Seed
$1M
Private Equity
$1.7M
Private Equity
$3.2M
Private Equity
$16M
Series A
$15M
Debt
$1M
Other Financing Round (2013): $250K with participation from Don Byrne
Angel/Seed (2014): $1M led by Don Byrne
Private Equity (2015): $1.7M supported by Don Byrne
Private Equity (2016): $3.2M, investors not publicly disclosed
Private Equity (2017): $16M backed by Cypress Growth Capital
Series A (2019): $15M, investors not publicly disclosed
Debt (2020): $1M led by PPP
Key Investors in Chartspan Medical Technologies
Cypress Growth Capital
Cypress Growth Capital is a venture capital firm specializing in providing royalty-based funding, offering flexible and non-dilutive growth capital tailored for emerging companies, particularly in the SaaS and tech-enabled services sectors. Their funding model allows businesses to retain equity while accessing necessary capital, with payments adjusting based on revenue performance.
What's next for Chartspan Medical Technologies?
The recent major strategic investment signals Chartspan Medical Technologies' intent to further scale its operations and enhance its technological capabilities. This influx of capital is likely to fuel product development, expand market reach, and strengthen partnerships within the value-based care ecosystem. As the healthcare industry continues its transition towards more patient-centric and outcome-driven models, ChartSpan is well-positioned to leverage this financing to solidify its leadership in chronic care management and drive further innovation in the sector.
See full Chartspan Medical Technologies company page
